COMPANY PROFILE

Reprieve Cardiovascular

Explore full profile

Led by a seasoned management team with extensive experience in the medical device industry

Milford, United StatesFounded 2018Health Tech & Medtech

Valuation $250–500M Last recorded · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Reprieve Cardiovascular

Reprieve Cardiovascular is a medical device company that develops and commercializes therapies for fluid management in patients suffering from acute decompensated heart failure (ADHF).

The company's core offering is a personalized decongestion management system that automates the management of a patient's fluid levels. This system is designed to enable clinicians to remove excess fluid from patients with ADHF safely and effectively.

Reprieve Cardiovascular operates in the cardiovascular medical device market, targeting a patient population of over 25 million individuals with heart failure globally. The company's business model is centered on the development and sale of its proprietary medical devices to hospitals and other healthcare facilities that treat acute heart failure.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Milford, United States
Employees: 34
Open positions: None listed
Dealroom signal: 89.8/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Cardiology and cardiovascular, Critical medical care, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Aug 2025	$61M	$244M	Arboretum Ventures · Rex Health Ventures · Genesis Capital · Sante Ventures	↗
SERIES AOther financing	Feb 2024	$42M	$168M	Sante Ventures · Deerfield · Genesis Capital · Arboretum Ventures	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Reprieve Cardiovascular website traffic

Latest recorded traffic for Reprieve Cardiovascular is 1.3K monthly website visits, down 35% over the last three months. Reprieve Cardiovascular's team grew 13.3% over the past year.

Latest monthly visits1.3K 3-month web change-35% 1-year team growth+13.3%

Monthly website visitsJun 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
VLVenstraMedical Pty LimitedDevelops and commercializes percutaneous circulatory support systems for temporary use by cardiologists in the treatment of patients requiring cardiac support without surgical intervention	Newcastle-Maitland, Australia	Operational	4	$3.9M	$8M
TMThornhill MedicalInnovative critical care solutions for combat, emergency, and humanitarian environments	Toronto, Canada	Operational
BIBioBeatBioBeat develops a cutting-edge wearable for continuous non-invasive accurate medical-grade monitoring of vital signs, including continuous blood pressure, saturation, respiratory rate, heart rate, consciousness, cardiac output, stroke volume, body t	Petah Tikva, Israel	Operational
ISInovytec Medical SolutionsInnovative solutions for out-of-hospital medical emergencies, enhancing survivability with advanced airway management and portable ventilators	Ra'anana, Israel	Operational
TTTongling Bionic TechnologyIntegrated lifecycle solutions for heart failure management	China	Operational
RORoddyMedicalDeveloping innovative medical devices that improve clinical safety and patient outcomes	Wauwatosa, United States	Operational
SASafeBVMA medical device startup working on inadvertent hyperventilation by healthcare providers during manual ventilation	Boston, United States	Operational
VEVentriFloTrue Pulse Pump is a novel, truly pulsatile blood pumping system designed to achieve superior outcomes, reduce costs and improve safety for pediatric & adult patients who require cardiopulmonary support during surgery or in the ICU	Pelham, United States	Operational